Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Methe, Heiko ^a   Edelman, Elazer R ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antibodies; Endothelial cell; Extracellular matrix; Immune system

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; CALCEIN AM; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; HETEROPHILE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL PROTECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; EFFECTOR CELL; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSPOT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; ANIMAL; AORTA; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CYTOLOGY; GRAFT REJECTION; IMMUNIZATION; IMMUNOLOGY; PHYSIOLOGY; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; VASCULAR ENDOTHELIUM; XENOGRAFT;

ANIMALS; ANTIBODIES, HETEROPHILE; AORTA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FLUORESCEINS; FLUORESCENT DYES; GRAFT REJECTION; IMMUNITY, CELLULAR; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; MICE; SPLEEN; SUS SCROFA; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33747195053     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.000687     Document Type: Article

References (25)

1. Pober JS. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol. 1988;133:426-433.
2. D'Anastasio C, Impallomeni M, McPherson GA, Clements WG, Howells GL, Brooks PA, Batchelor JR. Antibodies against monocytes and EC in the sera of patients with atherosclerotic peripheral arterial disease. Atherosclerosis. 1988;74:99-105.
3. Wangel AG, Kontiainen S, Scheinin T, Schlenzka A, Wangel D, Maenpaa J. Anti-EC antibodies in insulin-dependent diabetes mellitus. Clin Exp Immunol. 1992;88:410-413.
4. Frostegard J, Wu R, Gillis-Haegerstrand C, Lemne C, de Faire U. Antibodies to EC in borderline hypertension. Circulation. 1998;98:1092-1098.
5. Meroni P, Ronda N, Raschi E, Borghi MO. Humoral autoimmunity against endothelium: theory or reality? Trends Immunol. 2005;26:275-281.
6. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol. 2005;25:1776-1785.
7. Carvalho D, Savage CO, Isenberg D, Pearson JD. IgG anti-EC autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two EC-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum. 1999;42:631-640.
8. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998;8:437-441.
9. Kern A, Liu K, Mansbridge J. Modification of fibroblast gamma-interferon responses by extracellular matrix. J Invest Dermatol. 2001;117:112-118.
10. Stegemann JP, Nerem RM. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res. 2003;283:146-155.
11. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science. 2001;294:1708-1712.
12. Methe H, Nugent HM, Groothuis A, Seifert P, Sayegh MH, Edelman ER. Matrix embedding alters the immune response against EC in vitro and in vivo. Circulation. 2005;112:I89-I95.
13. + T cells by skin grafts via direct antigen presentation. J Immunol. 2002;169:1270-1276.
14. Facchini A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol. 1987;68:340-347.
15. Simeonovic CJ, Townsend MJ, Karupiah G, Wilson JD, Zarb JC, Mann DA, Young IG. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response. Cell Transplant. 1999;8:365-373.
16. Singh NP, Guo L, Mhoyan A, Shirwan H. Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection. Transplantation. 2003;75:586-590.
17. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation. J Immunol. 2000;164:2338-2346.
18. Ponticiello MS, Schingal RM, Kadiyala S, Barry FP. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res. 2000;52:246-255.
19. Centra M, Ratych RE, Cao GL, Li J, Williams E, Taylor RM, Rosen GM. Culture of bovine pulmonary artery EC on Gelfoam blocks. FASEB J. 1992;6:3117-3121.
20. Goerdt S, Steckel F, Schulze-Osthoff K, Hagemeier HH, Macher E, Sorg C. Characterization and differential expression of an EC-specific surface antigen in continuous and sinusoidal endothelial, in skin vascular lesions and in vitro. Exp Cell Biol. 1989;57:185-192.
21. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of EC by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol. 1988;106:1375-1384.
22. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol. 2005;169:191-202.
23. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
24. Shimizu A, Colvin RB. Pathological features of antibody-mediated rejection. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:199-214.
25. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 1992;339:1566-1570.